Register information Patent

DE file number : 60 2016 067 595.1 (Status: pending/in force, Query started: May 1, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2016 067 595.1
96EP file numberEAKZ16 72 4546.3
86WO file numberWAKZPCT/US2016/031223
97EP publication numberEPN3292206
87WO publication numberWPN2016179497
54Designation/titleTIGLUCOCEREBROSIDASE GENTHERAPIE VON MORBUS PARKINSON
51IPC main classICM
(ICMV)		 C12N 15/864 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 A61K 38/47 (2006.01), A61K 48/00 (2006.01), A61K 35/76 (2015.01), A61P 25/16 (2006.01), C12N 9/24 (2006.01)
22DE application dateDATMay 6, 2016
96EP application dateEATMay 6, 2016
86WO application dateWATMay 6, 2016
43Date of first publicationOTNov 10, 2016
Date of publication of grantPETDec 22, 2021
71/73Applicant/ownerINHTakeda Phamraceutical Co., Ltd., Osaka, JP; The McLean Hospital Corporation, Belmont, MA, US
72InventorINPARK, Yung Hee, Lexington, MA 02421, US; ISACSON, Ole, Belmont, MA 02478, US
74RepresentativeVTRMüller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE
Address for service Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201562158244 P
May 7, 2015
Due dateFT
FG		May 31, 2025
Annual fee for the 10th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003292206A1
Searchable text: EP000003292206A1
Original document: EP000003292206B1
Searchable text: EP000003292206B1
Original document: WO002016179497
Searchable text: WO002016179497
43Date of first publicationEVTNov 10, 2016
Date of the first transfer into DPMAregisterEREGTMar 14, 2018
Date of the (most recent) update in DPMAregisterREGTSep 26, 2024
(Show all update days)(Hide all update days)
  • Sep 26, 2024
    • St.36: changed (technical change)
  • Jun 8, 2024; May 9, 2024; Apr 26, 2024; Apr 28, 2023; Dec 15, 2022; Nov 10, 2022; Apr 29, 2022; Mar 9, 2022; Jan 4, 2022; Dec 22, 2021; Dec 2, 2021; Jun 24, 2021
    • Historical data not available for this/these date(s)
  • Mar 14, 2018
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to PCT application WO publication Nov 10, 2016  Details anzeigen
2 Procedure relating to EP application EPO 1st publication Mar 14, 2018  Details anzeigen
3 Publications Publication of a mention regarding EP 1st publication by DPMA Apr 26, 2018 Apr 26, 2018 Details anzeigen
4 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Dec 22, 2021  Details anzeigen
5 New applicant/owner details New applicant/owner details Jan 3, 2022  Details anzeigen
6 Publications Publication by DPMA of mention regarding EP patent grant Jan 5, 2022 Jan 5, 2022 Details anzeigen
7 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Sep 23, 2022 Dec 15, 2022 Details anzeigen
View procedures Procedure relating to PCT application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO publication
Date of legal/procedural statusVSTTNov 10, 2016
Date of update of the procedureREGTDec 2, 2021
View procedures Procedure relating to EP application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTMar 14, 2018
View procedures Publications (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTApr 26, 2018
Issue numberHN17
YearPJ2018
Publication dateVTApr 26, 2018
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTDec 22, 2021
Date of update of the procedureREGTDec 2, 2021
View procedures New applicant/owner details (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJan 3, 2022
71/73Previous applicant/ownerINHFShire Human Genetic Therapies, Inc., Lexington, MA, US, The McLean Hospital Corporation, Belmont, MA, US
Date of update of the procedureREGTJan 4, 2022
View procedures Publications (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTJan 5, 2022
Issue numberHN1
YearPJ2022
Publication dateVTJan 5, 2022
Type of publicationPARTBibliographic data
PartHTPart 5
Date of update of the procedureREGTDec 22, 2021
View procedures Procedure relating to EP application (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTSep 23, 2022
Issue numberHN50
YearPJ2022
Publication dateVTDec 15, 2022
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTDec 15, 2022